$38.4 Billion U.S. Commercial Weight Loss Market Pivots to Survive GLP-1 Drugs Explosion

Woman satisfied with the weight that holds a scale - isolated black backgroundThe $ 38 billion US commercial weight loss market is 15% higher than in 2020, but it had to turn to adapt to the huge competition of popular GLP-1 drugs. The big trading chains have been the most injured since 2022. The business has become virtual and some competitors added GLP-1 drugs to their programs to put themselves in a new future.

However, some commercial markets worked well. Dietary soft drinks showed a surprising force and placed high -protein meal replacements as a complement to weight loss drugs. The market for weight loss applications is increasing strongly. The series of commercial weight loss centers have become thinned and the franchise is only dead as a growth model.

Most important things you need to know about the American trade weight loss market

  • Areas of market dimensioning and decline: Marketdata estimates that the US trade (non-medical) weight loss market for programs, products and services was $ 38.4 billion in 2024, slightly reduced from $ 38.8 billion in 2022.
  • Dramatic effect of GLP-1 drugs: The market segment of commercial weight loss programs in 2023 was 29.2% to $ 3.24 billion and a further 23.7% to $ 2.47 billion in 2024 due to GLP-1 drug competition. This represents a 56% decline in just two years.
  • The GLP-1 revenue loss: Since 2022, commercial weight loss companies have lost $ 2 billion in revenue due to GLP-1 drug competition. Jenny Craig went bankrupt, the profile plan is closed and the Nutrisystem Private Capital Professor has debt problems.
  • Average Weight Loss Center Revenue: The annual revenue of the “average” weight loss center in 2022 was $ 646 250. But sales have declined since then, in 2024 to $ 484,000 per center.
  • Growth options: It is possible that commercial weight loss companies are some growth in the second half of 2025. The GLP-1 deficiency is over and complex pharmacies will have to make medication on May 22. Many choose less costly (non-medical) diet programs.
  • Switch to virtual models: The business became virtual. The operation of the retail, brick and mortar center or franchise in this era was too difficult, with increasing real estate and staff costs. Many businesses have turned away from a virtual shipping model that can be scalded more and faster and more profitable.
  • Flexible segments: Some weight loss market segments kept well: meal replacements, diet soft drinks and weight loss applications (increasing markets of $ 990 million).

Where can you know more

For deeper information please look at the new report The US Weight Loss and Diet Control Market: Commercial (non-medical) programs and products By Marketdata, which gives a comprehensive look at this rapidly changing market, including the following:

  • Dollar value and growth rate for all major commercial weight loss segments
  • The latest market trends and corporate developments
  • Status reports for diet soft drinks, artificial sweeteners, commercial weight loss centers, multi-level marketing diet plans, retail and MLM meal replacement and weight loss supplements, and low cal-cal frozen appetizers
  • Analysis of the Market of Medical Weight Loss Programs
  • Competition for MDS, Hospitals, Medical Clinical Chains and Telehealth
  • Operating proportion of extensive national/state commercial centers
  • Rankings and revenue for the most important commercial chains and competitors’ profiles

About the author: John Larosa is president of Marketdata LLC and author of the 100+ industry and market research. His research appears on the most popular media, including ABC, CNN, FOX, ForbesTo USA todayTo The Wall Street JournalTo The New York Timesand various commercial journals.

Leave a Comment